Non-myeloablative allogeneic stem cell transplant with fludarabine and reduced dose cyclophosphamide in acute myeloid leukemia for older adults with comorbidities-Reference-Cited by-同舟云学术

Non-myeloablative allogeneic stem cell transplant with fludarabine and reduced dose cyclophosphamide in acute myeloid leukemia for older adults with comorbidities

Published:2022-09-12 Issue:11 Volume:57 Page:1743-1745
ISSN:0268-3369
Container-title:Bone Marrow Transplantation
language:en
Short-container-title:Bone Marrow Transplant

Author:

Pizzola Christopher J.,Cioccio Joseph,Rakszawski Kevin L.,Nickolich Myles,Ehmann W. Christopher,Rybka Witold B.,Wirk Baldeep,Naik Seema^ORCID,Zheng Hong,Silar Brooke,Shike Hiroko,Zhou Shouhao,Mineishi Shin^ORCID,Minagawa Kentaro^ORCID,Claxton David F.^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Transplantation,Hematology

Link

https://www.nature.com/articles/s41409-022-01821-4.pdf

Reference12 articles.

1. Childs R, Clave E, Contentin N, Jayasekera D, Hensel N, Leitman S, et al. Engraftment kinetics after nonmyeloablative allogeneic peripheral blood stem cell transplantation: full donor T-cell chimerism precedes alloimmune responses. Blood. 1999;94:3234–41.

2. Khouri IF, Keating M, Korbling M, Przepiorka D, Anderlini P, O’Brien S, et al. Transplant-lite: induction of graft-versus-malignancy using fludarabine-based nonablative chemotherapy and allogeneic blood progenitor-cell transplantation as treatment for lymphoid malignancies. J Clin Oncol Off J Am Soc Clin Oncol. 1998;16:2817–24. https://doi.org/10.1200/JCO.1998.16.8.2817.

3. Khawaja MR, Perkins SM, Schwartz JE, Robertson MJ, Kiel PJ, Sayar H, et al. Cyclophosphamide/fludarabine nonmyeloablative allotransplant for acute myeloid leukemia. Am J Hematol. 2015;90:97–99. https://doi.org/10.1002/ajh.23875.

4. Nelson RP Jr, Yu M, Schwartz JE, Robertson MJ, Hromas R, Fausel CA, et al. Long-term disease-free survival after nonmyeloablative cyclophosphamide/fludarabine conditioning and related/unrelated allotransplantation for acute myeloid leukemia/myelodysplasia. Bone Marrow Transpl. 2010;45:1300–8. https://doi.org/10.1038/bmt.2009.348.

5. Sorror ML, Maris MB, Storb R, Baron F, Sandmaier BM, Maloney DG, et al. Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT. Blood. 2005;106:2912–9. https://doi.org/10.1182/blood-2005-05-2004.